Mach7 Technologies (ASX:M7T) Change In Receivables : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies Change In Receivables?

Mach7 Technologies's change in receivables for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means Mach7 Technologies's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Mach7 Technologies's change in receivables for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means Mach7 Technologies's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Mach7 Technologies's Accounts Receivable for the quarter that ended in Dec. 2023 was A$4.77 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mach7 Technologies's Days Sales Outstanding for the six months ended in Dec. 2023 was 65.31.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mach7 Technologies's liquidation value for the six months ended in Dec. 2023 was A$6.94 Mil.

Mach7 Technologies Change In Receivables Historical Data

The historical data trend for Mach7 Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies Change In Receivables Chart

Mach7 Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

Mach7 Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Mach7 Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Mach7 Technologies (ASX:M7T) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Mach7 Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.771	/	13.332	*	91
=	65.31

2. In Ben Graham's calculation of liquidation value, Mach7 Technologies's accounts receivable are only considered to be worth 75% of book value:

Mach7 Technologies's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	22.729	-	19.367	+	0.75 * 4.771	+	0.5 * 0
=	6.94

Mach7 Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Mach7 Technologies (ASX:M7T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403

Website

https://www.mach7t.com

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines